Hematopoietic stem cell transplantation following unsuccessful salvage treatment for relapsed acute lymphoblastic leukemia in children

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 4, 2015-04 ,pp. : 674-679

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic‐driven approach and itraconazole oral solution

By  

MYCOSES (ELECTRONIC), Vol. 58, Iss. 12, 2015-12 ,pp. : 694-698

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and Down syndrome

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 1, 2015-01 ,pp. : 148-152

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of early remission by induction therapy on allogeneic stem cell transplantation for acute myeloid leukemia with an intermediate‐risk karyotype in first complete remission

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 5, 2015-05 ,pp. : 431-438

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome–positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

By  

CANCER, Vol. 122, Iss. 19, 2016-10 ,pp. : 2941-2951

John Wiley & Sons Inc

Access to resources Recommend Favorite